FlexifyMe raises 20 Cr in pre-Series A round led by IvyCap Ventures

Health-tech company FlexifyMe has raised Rs 20 crore ($2.4 million) in pre-Series A funding led by IvyCap Ventures with participation from Signal Ventures and existing investors.

author-image
Gyan Vardhan
New Update
flexifyme

Health-tech company FlexifyMe has raised Rs 20 crore ($2.4 million) in pre-Series A funding led by IvyCap Ventures with participation from Signal Ventures and existing investors.

Previously, the company has raised a $1 million in a seed funding round led by Flipkart Ventures and featured on Shark Tank India Season 3, where it secured investment fromNamita Thapar (Emcure).

The fresh funds will be utilized to accelerate its hybrid care expansion (online and offline centres), the launch of advanced posture and gait analysis labs, and the strengthening of clinical research partnerships, FlexifyMe said in a press release.

Co-founded in 2021 by Manjeet Singh and Amit Bhayani, FlexifyMe combines AI-driven posture and motion analysis with expert physiotherapy to identify the root causes of chronic musculoskeletal pain. By moving away from subjective, symptom-based care to data-driven, trackable interventions, the company helps reduce unnecessary procedures and improve long-term patient outcomes.

“By combining technology, licensed physiotherapists and rigorous progress tracking, we are making the journey to a pain-free life scientific, objective and measurable. This funding allows us to scale these capabilities so millions can avoid unnecessary surgeries, return to the activities they love, and regain meaningful quality of life,” said Manjeet Singh, co-founder, FlexifyMe.

The Pune-based platform provides live one-on-one sessions with certified instructors, personalized programs, and guided video sessions, drawing on a blend of traditional wisdom and cutting-edge technology

FlexifyMe says that it is already trusted by thousands of users across India and global markets. It works with enterprises, insurers, and healthcare ecosystems to deliver clinically validated outcomes.

Fetch New URL